DMAA Insider Trading Activity and SEC Form 4 Filings
DMAA insider trading summary
No open-market insider purchases or sales of Drugs Made In America Acquisition Corp. (DMAA) have been reported on SEC Form 4 in the past 12 months.
Latest DMAA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 18, 2025 | Lynn Stockwell | CEO and Exe. Chair of Board | Buy | $0 (30,000 @ $0.00) |
| Feb 18, 2025 | Drugs Made In America Acquisition LLC | 10% Owner | Buy | $0 (30,000 @ $0.00) |
| Jan 29, 2025 | Lynn Stockwell | CEO and Executive COB | Buy | $0 (400,000 @ $0.00) |
| Jan 29, 2025 | Lynn Stockwell | CEO and Executive COB | Sell | $0 (5,698,363 @ $0.00) |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC | 10% Owner | Buy | $0 (400,000 @ $0.00) |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC | 10% Owner | Sell | $0 (5,698,363 @ $0.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.